TipRanks
Addex Therapeutics (CH:ADXN)
:ADXN
Switzerland Market
ADXN
Addex Therapeutics
RESEARCH TOOLSreports
Want to see CH:ADXN full AI Analyst Report?

Addex Therapeutics (ADXN) Income Statement

2 Followers

Addex Therapeutics Income Statement

Last quarter (Q2 2026), Addex Therapeutics's total revenue was CHF9.95K, a decrease of -66.53% from the same quarter last year. In Q2, Addex Therapeutics's net income was CHF-1.75M. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Dec 22Dec 21
Total Revenue
CHF 173.00KCHF 410.04KCHF 1.61MCHF 1.42MCHF 2.92M
Gross Profit
CHF 164.39KCHF -444.26KCHF -5.32MCHF -13.20MCHF -9.67M
Operating Expenses
CHF 2.99MCHF 2.31MCHF 2.67MCHF 3.76MCHF 5.84M
Depreciation and Amortization
CHF 8.47KCHF 260.12KCHF 305.95KCHF 323.14KCHF 347.61K
EBITDA
CHF -2.81MCHF -4.65MCHF -10.26MCHF -20.43MCHF -14.94M
Operating Income
CHF -2.81MCHF -2.76MCHF -2.24MCHF -20.52MCHF -15.51M
Other Income/Expenses
CHF -4.03MCHF -2.15MCHF -257.19KCHF -284.01KCHF 154.00K
Pretax Income
CHF -6.84MCHF -4.91MCHF -2.50MCHF -20.80MCHF -15.35M
Net Income
CHF -6.73MCHF 7.06MCHF -10.56MCHF -20.80MCHF -15.41M
Per Share Metrics
Basic EPS
CHF -0.06CHF 0.07CHF -0.14CHF -0.46CHF -0.45
Diluted EPS
CHF -0.06CHF 0.07CHF -0.14CHF -0.46CHF -0.45
Weighted Average Shares Outstanding
 112.15M 98.11M 74.31M 45.18M 34.12M
Weighted Average Shares Outstanding (Diluted)
 112.15M 98.34M 74.31M 45.18M 34.12M
Currency in CHF

Addex Therapeutics Earnings and Revenue History